Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 30, 2000 - Issue 6
155
Views
68
CrossRef citations to date
0
Altmetric
Research Article

Regional and cellular distribution of CYP2D subfamily members in rat brain

, , , , &
Pages 547-564 | Published online: 22 Sep 2008

References

  • ALLARD, P., MARCUSSON, J. O. and Ross, S. B., 1994, [3]GBR-12935 binding to cytochrome P450 in the human brain. Journal of Neurochemistry, 62, 342–348.
  • BERGH, A. F. and STROBEL, W., 1996, Anatomical distribution of NADPH-cytochrome P450 reductase and cytochrome P4502D forms in rat brain: effects of xenobiotics and sex steroids. Molecular and Cellular Biochemistry, 162, 31–41.
  • BHAGWAT, S. V., BOYD, M. R. and RAVINDRANATH, V., 1995, Brain mitochondrial cytochromes P450: Xenobiotic metabolism, presence of multiple forms and their selective inducibility. Archives in Biochemistry and Biophysics, 320, 73–83.
  • BHAMRE, S., ANANDATHEERTHAVARADA, H. K., SHANKAR, S. K., BOYD, M. R. and RAVINDRANARTH, V., 1993, Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activities. Archives in Biochemistry and Biophysics, 301, 251–255.
  • BRADFORD, M. M., 1976, A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Annals of Biochemistry, 72, 248–254.
  • BRITT°, M. R. and WEDLUND, P. J., 1992, Cytochrome P0450 in the brain. Potential evolutionary and therapeutic relevance of localization of drug-metabolizing enzymes. Drug Metabolism and Disposition, 20, 446–450.
  • BROSEN, K., ZEUGIN, T. and MEYER, U. A., 1991, Role of P450I1D6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine. Clinical Pharmacology and Therapeutics, 49, 609–617.
  • CRIBB, A., Nuss, C. and WANG, R., 1995, Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6. Drug Metabolism and Disposition, 23, 671–675.
  • ELEXPURU-CAMIRUAGA, J., BUXTON, N., KANDULA, V., DIAS, P. S., CAMPBELL, D., MCINTOSH, J., BROOME, J., JoNEs, P., INSKIP, A., ALLDERSEA, J. et al., 1995, susceptibility of astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Research, 55, 4237–4239.
  • GHERSI-EGEA, J.-F., LENINGER-MULLER, B., SULEMAN, G., SIEST, G. and MINN, A., 1994, Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. Journal of Neurochemistry, 62, 1089–1096.
  • GHERSI-EGEA, J.-F., PERRIN, R., LENINGER-MULLER, B., GRASSIOT, M.-C., JEANDEL, C., FLOQUET, J., CUNY, G., SIEST, G. and MINN, A., 1993, Subcellular localization of cytochrome P450 and activities of several enzymes responsible for drug metabolism in the human brain. Biochemical Pharmacology, 45, 647–658.
  • GILHAM, D. E., CAIRNS, W., PAINE, M. J., MODI, S., POULSOM, R., ROBERTS, G. C. and WOLF, C. R., 1997, Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization. Xenobiotica, 27, 111–125.
  • GONZALEZ, F. J., MATSUNAGA, T., NAGATA, K., MEYER, U. A., NEBERT, D. W., PASTEWKA, J., KOZAK, C. A., GILLETTE, J. GELBOIN, H. V. and HARDWICK, J. P., 1987, Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism. DNA, 6, 149–161.
  • HADLEY, W. M. and DAHL, A. R., 1982, Cytochrome P-450 dependent monooxygenase activity in rat nasal epithelial membranes. Toxicology Letters, 10, 417–422.
  • HANSSON, T., VON BAHR, C., MARKLUND, M., SVENSSON, J.-0., INGELMAN-SUNDBERG, M. and LUNDSTROM, J., 1992, Different regiospecificity in the hydroxylation of the antidepressant desmethylimipramine between rat brain and liver. Pharmacology and Toxicology, 71, 416–419.
  • ISCAN, M., REUHL, K., WEISS, R. and MAINES, M. D., 1990, Regional and subcellular distribution of cytochrome P-450-dependent drug metabolism in monkey brain: the olfactory bulb and the mitochondrial fraction have high levels of activity. Biochemical and Biophysical Research Communications, 169, 858–863.
  • JOLIVALT, C., MINN, A., VINCENT-VIRY, M., GALTEAU, M.-M. and SIEST, G., 1995, Dextromethorphan 0-demethylase activity in rat brain microsomes. Neuroscience Letters, 187, 65–68.
  • KAWASHIMA, H., SEQUEIRA, D. J., NELSON, D. R. and STROBEL, H. W., 1996, Genomic cloning and protein expression of a novel rat brain cytochrome P-450 CYP2D18* catalyzing imipramine N-demethylation. Journal of Biological Chemistry, 271, 28176–28180.
  • KOMORI, M., 1993, A novel P450 expressed at high level in rat brain. Biochemical and Biophysical Research Communications, 196, 721–728.
  • KRISHNA, D. R. and KLOTZ, U., 1994, Extrahepatic metabolism of drugs in humans. Clinical Pharmacokinetics, 26, 144–160.
  • LAURENZANA, E. M. and OWENS, S. M., 1997, Brain microsomal metabolism of phencyclidine in male and female rats. Brain Research, 756, 256–265.
  • LOEPER, J., DESCATOIRE, V., MAURICE, M., BEAUNE, P., BELGHITI, J., HOUSSIN, D., BALLET, F., FELDMANN, G., GUENGERICH, F. P. and PESSAYRE, D., 1993, Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology, 104, 203–216.
  • MATSUNAGA, E., UMENO, M. and GONZALEZ, F. J., 1990, The rat P45 011D subfamily: complete sequences of four closely linked genes and evidence that gene conversions maintained sequence homogeneity at the heme-binding region of the cytochrome P450 active site. Journal of Molecular Evolution, 30, 155–169.
  • MATSUNAGA, E., ZANGER, U. M., HARDWICK, J. P., GELBOIN, H. V., MEYER, U. A. and GONZALEZ, F. J., 1989, The CYP2D gene subfamily: analysis of the molecular basis of the debrisoquine 4-hydroxylase deficiency in DA rats. Biochemistry, 28, 7349–7355.
  • MEYER, U. A., SKODA, R. C. and ZANGER, U. M., 1990, The genetic polymorphism of debrisoquine/ sparteine metabolism - molecular mechanisms. Pharmacology and Therapeutics, 46, 297–308.
  • NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, 0., OKUDA, K. and NEBERT, D. W., 1993, The P450 superfamily - update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclatures. DNA Cell Biology, 12, 1–51.
  • NIZNIK, H. B., TYNDALE, R. F., SALLEE, F. R., GONZALEZ, F. J., HARDWICK, J. P., INABA, T. and KALO W., 1990, The dopamine transporter and cytochrome P450IID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [311]GBR-12935 binding proteins. Archives in Biochemistry and Biophysics, 276, 424–432.
  • NORRIS, P. J., HARDWICK, J. P. and EMSON, P. C., 1996, Regional distribution of cytochrome P450 2D1 in the rat central nervous system. Journal of Comp. Neurology, 366, 244–258.
  • OHISHI, N., IMAOKA, S., SUZUKI, T. and FUNAE, Y., 1993, Characterization of two P-450 isozymes placed in the rat CYP2D subfamily. Biochimica et Biophyska Acta, 1158, 227–236.
  • OHMORI, O., SUZUKI, T., KOJIMA, H., SHINKAI, T., TERAO, T., MITA, T. and ABE, K., 1998, Tardive dyskinesia and debrisoquine 4-hydroxylase (CYP2D6) genotype in Japanese schizophrenics. Schizophrenia Research, 32, 107–113.
  • PARKINSON, A., 1996, Biotransformation of xenobiotics. In C. D. Klasson (ed.), Casarett and Doull' s Toxicology: The Basic Science of Poisons, 5th edn (New York: McGraw-Hill), pp. 113–185.
  • PASANEN, M. and PELKONEN, O., 1994, The expression and environmental regulation of P450 enzymes in human placenta. Critical Reviews in Toxicology, 24, 211–229.
  • PAXINOS, G. and WATSON, C., 1986, The Rat Brain in Stereotaxic Coordinates, 2nd edn (San Diego: Academic Press).
  • RIEDL, A. G., BROWN, C. T., ROSE, S., SCHULZ-UTERMOEHL, T., EDWARDS, R. J., BOOBIS, A. R. and JENNER, P., 1998b, Localisation of CYP2D enzymes in naive rat basal ganglia. Proceedings of the BPS, December 1997. British Journal of Pharmacology, 123 (suppl.).
  • RIEDL, A. G., WATTS, P. M., EDWARDS, R. J., SCHULZ-UTERMOEHL, T., BOOBIS, A. R., JENNER, P. and MARSDEN, C. D., 1999, Expression and localisation of CYP2D enzymes in rat basal ganglia. Brain Research, 822, 175–191.
  • RIEDL, A. G., WATTS, P. M., JENNER, P. and MARSDEN, C. D., 1998a, P450 enzymes and Parkinson's disease: the story so far. Mov Disorder, 13, 212–220.
  • TANAKA, S., CHEN, X., XIA, Y., KANG, D. E., MATOH, N., SUNDSMO, M., THOMAS, R. G., KATZMAN, R., THAL, L. J., TROJANOWSKI, J. Q. SAITOH, T. UEDA, K. and MASLIAH, El, 1998, Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease. Neurology, 50, 1556–1562.
  • TYNDALE, R. F., LI, Y., LI, N.-Y., MESSINA, E., MIKSYS, S. and SELLERS, E. M., 1999, Characterization of CYP2D1 activity in rat brain: high affinity kinetics for dextromethorphan. Drug Metabolism and Disposition, 27, 924–930.
  • TYNDALE, R. F., SUNAHARA, R., INABA, T., KALOW, W., GONZALEZ, F. J. and NIZNIK, H. B., 1991, Neuronal cytochrome CYP2D1 (debrisoquine/sparteine-type): potent inhibition of activity by (—)-cocaine and nucleotide sequence identity with human hepatic P450 gene CYP2D6. Molecular Pharmacology, 40, 63–68.
  • WAN, J., IMAOKA, S., CHOW, T., HIROI, T., YABUSAKI, Y. and FUNAE, Y., 1997, Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity. Archives in Biochemistry and Biophysics, 348, 383–390.
  • WARNER, M., HILLMOLD, H., YOSHIDA, S., LIAO, D., HEDLUND, E. and GUSTAFSSON, J.-A., 1997, Cytochrome P450 in the breast and brain: role in tissue-specific activation of xenobiotics. Mutation Research, 376, 79–85.
  • Wu, D., OTTON, V. S., MORROW, P., INABA, T., KALOW, W. and SELLERS, E. M., 1993, Human hepatic cytochrome P450 2D6-like activity in nonhuman primates: catalytic characterization in vitro. Journal of Pharmacology and Experimental Therapeutics, 266, 715–719.
  • WUNDRACK, I., MEESE, E., MULLENBACH, R. and BU N., 1994, Debrisoquine hydroxylase gene polymorphism in meningioma. Acta Neuropathologica (Berlin), 88, 472–474.
  • Wyss, A., GUSTAFSSON, J.-A. and WARNER, M., 1995, Cytochromes P450 of the 2D subfamily in the rat brain. Molecular Pharmacology, 47, 1148–1155.
  • XIE, W. and ROTHBLUM, L. I., 1991, Rapid, small-scale RNA isolation from tissue culture cells. Biotechniques, 11, 325–327.
  • YAMAMOTO, Y., NAKAMURA, A., TASAKI, T., UMEDA, S., SUGIMOTO, C., IAOKA, S., FUNAE, Y., MASUDA, M., KAZUSAKA, A. and FuJITA, S., 1996, Impaired expression in DA rats of catalytically active p45Obtl immunochemically distinguishable from p45 02d1 : immunological evidence with specific antipeptide antibodies. Biomedical Research, 17, 331–337.
  • YAMAMOTO, Y., TALAKI, T., NAKAMURA, A., IWATA, H., KAZUSAKA, A., GONZALIZ, F. J. and FUJITA, S., 1998, Molecular basis of the dark agouti rat drug oxidation polymorphism: importance of CYP2D1 and CYP2D2. Pharmacogenetks, 8, 73–82.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.